UTHSC Researchers Studying Why People Grow Old
The University of Tennessee Health Science Center researcher, Dr. Khyobeni Mozhui, launches study on what governs how people grow old.
The University of Tennessee Health Science Center researcher, Dr. Khyobeni Mozhui, launches study on what governs how people grow old.
The University of Tennessee Health Science Center, Memphis Bioworks Foundation, and TriMetis Life Sciences have announced the establishment of a partnership focused on research, discovery, entrepreneurship and commercialization in biosciences and technology.
A Memphis doctor who knows first-hand the pain of losing a child to an overdose is fighting to change medical education in Tennessee so there are more physicians throughout the state with addiction medicine expertise. Dr. David Stern, vice-chancellor for clinical affairs for the University of Tennessee’s College of Medicine and the University of Tennessee… Read More
University of Tennessee Health Science Center College of Pharmacy Dean reflects on her childhood and the lessons she learned from her parents which ultimately led to her being the first in her family to graduate from high school, college, and pharmacy school.
For those of you paying for college at Tennessee schools, how does a less than 3% college tuition increase sound? Or a warranty for what you learn? Those are just some of the things that came out budget hearings Tuesday before Governor Bill Haslam. The Governor’s budget hearings every fall provide a window on spending… Read More
The University of Tennessee Health Science Center (UTHSC) is in the midst of more than $20 million in state-funded security upgrades. “We went from about 300 cameras right now to about 1,200 cameras being installed campus wide,” UTHSC Police Chief Anthony Berryhill said. The enhancements will also include keyless locks on buildings and an emergency… Read More
The University of Tennessee Health Sciences Center is near completion on its effort to convert a warehouse on the eastern side of its campus into a $20 million pharmaceutical manufacturing facility that will target rare disease drugs.